BioCentury | May 9, 2016
Financial News

Vitaeris completes venture financing

...Autoimmune, Inflammation Date completed: 2016-05-06 Type: Venture financing Raised: $7 million Investors: HBM Healthcare Investments; Machall Group...
BioCentury | May 7, 2016
Company News

Newco Vitaeris licenses Alder's clazakizumab

...him in December about creating a newco for clazakizumab. Hall is managing partner at the Machall Group...
Items per page:
1 - 2 of 2
BioCentury | May 9, 2016
Financial News

Vitaeris completes venture financing

...Autoimmune, Inflammation Date completed: 2016-05-06 Type: Venture financing Raised: $7 million Investors: HBM Healthcare Investments; Machall Group...
BioCentury | May 7, 2016
Company News

Newco Vitaeris licenses Alder's clazakizumab

...him in December about creating a newco for clazakizumab. Hall is managing partner at the Machall Group...
Items per page:
1 - 2 of 2